Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Dexcom Inc banner

Dexcom Inc
SWB:DC4

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
SWB:DC4
Watchlist
Price: 64.4 EUR -1.83%
Market Cap: €47.8B
Write Note Create Alert Ask AI

Wall St Price Targets

DC4 Price Forecast
Based on 28 analysts

+28% Upside
from €64.4 today

DC4 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for DC4 yet.

Dexcom Inc Competitors:
Price Targets

Revenue
Forecast

34% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
34% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 12%.

What are analyst estimates?

Gross Profit
Forecast

37% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
37% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 5 years is 14%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

The compound annual growth rate for Operating Income over the next 5 years is 19%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

The compound annual growth rate for Net Income over the next 5 years is 19%.

What are analyst estimates?

Continue DC4 Research

Summary
DC4 intrinsic value, competitors valuation, and company profile.
DCF Valuation
DC4 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DC4 stock valuation using valuation multiples.
Wall St Estimates
DC4 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DC4 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Dexcom Inc listings:
NASDAQ • USD
DXCM
 F • EUR
DC4
 XMUN • EUR
DC4
 XETRA • EUR
DC4
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DC4's stock price target?
Price Target
82.68 EUR

According to Wall Street analysts, the average 1-year price target for DC4 is 82.68 EUR with a low forecast of 65.32 EUR and a high forecast of 104.13 EUR.

What is the Revenue forecast for Dexcom Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 12%.

What is the Gross Profit forecast for Dexcom Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 5 years is 14%.

What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
19%

The compound annual growth rate for Operating Income over the next 5 years is 19%.

What is the Pre-Tax Income forecast for Dexcom Inc?
Projected CAGR
19%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.

What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%

The compound annual growth rate for Net Income over the next 5 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.